Earnings · US stocks

SELLAS Life Sciences Group, Inc. (SLS) earnings

SELLAS Life Sciences Group, Inc. published its quarterly report on 2026-11-12. The stock moved +138.48% in the 3 trading days after the report.

Report
quarterly report
Published
2026-11-12
Result
Bad / loss
Open earnings in Wave Radar

Stock move after the report

Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.

AfterReturnvs index
1 day-2.12%—
3 days+138.48%—

Report history

Over the last 8 reports, EPS beat the consensus estimate in 6 of them. The stock rose in the 3 trading days after 6 of 8 reports (average +20.52%).

PublishedEPSEPS surprise3 days after30 days after30d vs index
2026-11-12-0.05—+138.48%——
2026-08-11-0.05-11.11%+15.66%+4.25%+4.61%
2026-03-19-0.05+21.05%-3.85%-5.19%-14.41%
2025-11-12-0.06+21.74%-5.37%+92.62%+91.60%
2025-08-12-0.07+8.70%+1.24%+1.24%-1.62%
2025-05-13-0.07+34.38%+15.60%+43.97%+39.71%
2025-03-20-0.08+25.00%+0.83%+43.80%+43.58%
2024-11-13-0.10+21.05%+1.57%-22.83%-22.47%

The last 8 reported quarters. Moves count trading days from the first tradeable session after the report; "30d vs index" is the excess return over the market index.

Stock valuations: SLS · Stock news: SLS

How to read this

Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.

Figures are generated automatically from Wave Radar's published market data and refresh after each market close.